Interleukin 9

Interleukin 9, also known as IL-9, is a cytokine (cell signalling molecule) belonging to the group of interleukins.

Function

The protein encoded by this gene is a cytokine produced by T-cells and specifically by CD4+ helper cells that acts as a regulator of a variety of hematopoietic cells. This cytokine stimulates cell proliferation and prevents apoptosis. It functions through the interleukin-9 receptor (IL9R), which activates different signal transducer and activator (STAT) proteins and thus connects this cytokine to various biological processes. The gene encoding this cytokine has been identified as a candidate gene for asthma. Genetic studies on a mouse model of asthma demonstrated that this cytokine is a determining factor in the pathogenesis of bronchial hyperresponsiveness.

Interleukin-9 has also shown to inhibit melanoma growth in mice.

References

Further reading

Podcasts:

PLAYLIST TIME:

Latest News for: interleukin 9

Edit

The Interleukin-2 Market is Set to Reach USD 4 Billion by 2034, Driven by IL-2 Targeting Fusion Proteins, Monoclonal antibodies, and Gene Therapies Across Immunology, Dermatology, Neurodegenerative Disorders, and Oncology | DelveInsight

PR Newswire 27 Mar 2025
Learn more about the IL-2 treatment landscape @ Interleukin-2 Therapeutic Landscape ... To know more about FDA-approved IL-2 inhibitors, visit @ Approved Interleukin-2 Drugs ... @ Interleukin-2 Market Report.
Edit

Interleukin-2 Market Size, Target Population, Competitive Landscape & Market Forecast to 2034: Japan Leads Interleukin-2 ...

Nasdaq Globe Newswire 20 Mar 2025
The Interleukin-2 (IL-2) market is set for significant expansion through 2034, driven by growing cancer and autoimmune disease cases, FDA approvals, and innovative pipeline therapies ... The Interleukin-2 ...
  • 1
×